Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials
Enveda is a drug discovery and development company using the latest AI-powered technologies to translate nature into new medicines.
- Enveda is a drug discovery and development company using the latest AI-powered technologies to translate nature into new medicines.
- Enveda’s lead program for atopic dermatitis is a novel oral first-in-class anti-inflammatory agent that has demonstrated remarkable efficacy and high safety margins in preclinical studies.
- “At Premji Invest, we seek to partner with exceptional teams to build companies that can create long-term value.
- “Enveda has made significant progress in creating a platform that learns from the diversity in natural chemistry and is able to translate this knowledge to develop novel therapeutics.